MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Long-term effects of air pollution on the risk of Parkinson’s disease

    Y.S Hwang, S.Y Jo, Y.J Kim, K.W Park, S.H Lee, S.J Chung (Seoul, Republic of Korea)

    Objective: We aimed to investigate the association between air pollution, including fine particulate matter (particles 2.5 mm in diameter, or PM2.5), and the risk of…
  • MDS Virtual Congress 2020

    Premotor compensatory mechanisms in Parkinson’s disease with LRRK2-R1441H mutation

    S. Sambin, S. Lavisse, C. Decaix, G. Mangone, F. Cormier, B. Le Toullec, S. Lesage, P. Remy, A. Brice, J.C Corvol (Paris, France)

    Objective: To investigate the time course of modifications in dopaminergic terminals during the premotor phase in LRRK2 genetically determined Parkinson’s disease (PD). Background: Increased dopamine…
  • MDS Virtual Congress 2020

    Video-to-Home Cognitive-Behavioral Therapy for Veterans with Depression and Parkinson’s Disease: A Randomized Controlled Trial

    R. Dobkin, S. Mann, K. Rodriguez, L. St. Hill, R. Miller, A. King, M. Gara, A. Interian (Piscataway, NJ, USA)

    Objective: For the nearly 100,000 veterans with Parkinson’s disease (PD) receiving Veterans Affairs (VA) health care, depression is prevalent, yet often undiagnosed or undertreated. This…
  • MDS Virtual Congress 2020

    Mental Health Matters Too – Integration of physical and mental health in a multidisciplinary Parkinson’s Clinic

    C. Taylor, C. Johnson, J. Marsh, L. Brown, A. Silverwood, R. Stringer, C. Cooper, R. Skelly (Derby, United Kingdom)

    Objective: The overall aim of the project was to demonstrate that people with Parkinson’s disease benefit from good mental health care when mental health services…
  • MDS Virtual Congress 2020

    Effect of Combined Modality Treatment on Sustained Phonation in Parkinson’s Disease

    M. Cannito, N. Roussel, J. Tetnowski, K. Schiller, M. LeDoux, E. Buder, C. Royal-Evans, S. Narayana (Lafayette, LA, USA)

    Objective: To determine whether Lee Silverman Voice Treatment (LSVT-LOUD(R)) combined with Transcranial Magnetic Stimulation in individuals with Parkinson's disease (PD) improves phonation to a greater…
  • MDS Virtual Congress 2020

    Pridopidine for the treatment of Levodopa-induced Dyskinesia in patients with Parkinson’s disease

    M. Geva, A. McGarry, Y. Cohen, T. Johnston, M. de Somer, K. Kieburtz, M. Hayden, J. Brotchie, C. Olanow (Herzliya, Israel)

    Objective: To assess the efficacy and safety of pridopidine in PD patients with Levodopa-induced dyskinesia (LID). Background: Pridopidine is a small molecule in clinical development…
  • MDS Virtual Congress 2020

    Phase I-II first-in-human clinical study of intraputamenal CDNF in Parkinson’s disease: Exploratory PET imaging endpoints of the 12-month treatment period

    V. Kerstens, P. Fazio, J. Johansson, T. Granberg, S. Booms, H. Huttunen, M. Sjögren, M. Woolley, B. Murphy, P. Fielder, J. Baker, P. Skinner, M. Andreasson, G. Paul-Visse, R. Kivisaari, H. Bjartmarz, G. Lind, P. Almqvist, F. Scheperjans, H. Widner, P. Svenningsson, J. Rinne, A. Varrone (Stockholm, Sweden)

    Objective: To test if intermittent intraputamenal monthly infusions of CDNF have an effect on striatal dopamine transporter (DAT) binding, as measured by PET, in subjects…
  • MDS Virtual Congress 2020

    CHIEF-PD: Cholinesterase Inhibitor to prEvent Falls in Parkinson’s Disease

    S. Neumann, J. Taylor, A. Bamford, C. Metcalfe, D.M Gaunt, A. Whone, D. Steeds, S.R Emmett, W. Hollingworth, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

    Objective: Preventing falls in people with Parkinson’s disease has the potential to reduce hospital admissions and improve quality of life by diminishing the significant morbidity…
  • MDS Virtual Congress 2020

    Are effects of Rock Steady Boxing and PD SAFExTM on the motor symptoms of Parkinson’s disease maintained long-term? – A single-blinded randomized controlled trial

    K. Sangarapillai, B. Norman, Q. Almeida (Waterloo, ON, Canada)

    Objective: To determine if the benefits associated with RSB and PD SAFExTM on the motor symptoms of PD wash out over time. Background: Parkinson’s disease…
  • MDS Virtual Congress 2020

    Remote video-based research visits in a phase 3 clinical trial in Parkinson’s disease

    C. Tarolli, K. Andrzejewski, G. Zimmerman, M. Bull, S. Goldenthal, P. Auinger, E.R Dorsey, K. Biglan, T. Simuni (Rochester, NY, USA)

    Objective: To assess the feasibility, reliability, and value of remote visits in a phase 3 trial of individuals with Parkinson's disease (PD). Background: Remote video-based…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley